Urotronic Inc.
10 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| EvaluatioN of Optilume Drug-Coated Balloon for the Endoscopic Treatment of UREteric Strictures (NCT07020520) | Urotronic Inc. | 2025-10-01 |
| OPtilume™ BPH Catheter SystEm for Treatment of Men eXperiencing Symptomatic BPH (NCT06560476) | Urotronic Inc. | 2024-03-30 |
| Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study (NCT06312722) | Urotronic Inc. | 2024-02-07 |
| Optilume PoST AppRoval Clinical Evaluation of Andrology ParaMeters (NCT05383274) | Urotronic Inc. | 2022-02-14 |
| Optilume™ BPH Catheter System in Men With Symptomatic BPH (NCT04131907) | Urotronic Inc. | 2020-02-05 |
| Re-Establishing Flow Via Drug Coated Balloon for the Treatment of Urethral Stricture Disease - Registry Study (NCT03851952) | Urotronic Inc. | 2019-05-31 |
| ROBUST III- Re-Establishing Flow Via Drug Coated Balloon For The Treatment Of Urethral Stricture Disease (NCT03499964) | Urotronic Inc. | 2018-06-22 |
| Optilume™ BPH Prostatic Drug Coated Balloon Dilation Catheter (NCT03423979) | Urotronic Inc. | 2017-12-19 |
Track Urotronic Inc. automatically
Every clearance here is in the API, with alerts when new ones post.